The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer

Endocrine therapy has successfully been used to treat estrogen receptor (ER)-positive breast cancer, but this invariably fails with cancers becoming refractory to treatment. Emerging evidence has suggested that fluctuations in ER co-regulatory protein expression may facilitate resistance to therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade, Mark A., Jones, Dominic, Wilson, Laura, Stockley, Jacqueline, Coffey, Kelly, Robson, Craig N., Gaughan, Luke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Gene regulation, Chromatin and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288188/
https://www.ncbi.nlm.nih.gov/pubmed/25488809
http://dx.doi.org/10.1093/nar/gku1298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288188/
https://www.ncbi.nlm.nih.gov/pubmed/25488809
http://dx.doi.org/10.1093/nar/gku1298

Ejemplares similares